A small observational study suggests that initiating immunotherapy early may improve seizure outcome in patients with medically intractable epilepsy for whom clinical and serological clues suggest an autoimmune basis. At an average of 17 months after these patients received immunotherapy, 81% reported improvements and 66% were seizure free.
Abstract: Archives of Neurology, May 2012.
